型号:
产品价格:电议      采购度:1604      原产地:美洲
发布时间:2021/6/23 8:47:03 所属地区:国外 国外
简要描述:
GSK046 (iBET-BD2) 是一种有效,选择性和具有口服活性的 BET 蛋白 BD2 溴结构域的抑制剂,IC50 值为 264 nM (BRD2 BD2),98 nM (BRD3 BD2),49 nM (BRD4 BD2) 和 214 nM (BRDT BD2)。GSK046 具有免疫调节活性。
标签:iBET-BD2
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 2474876-09-8
MCE 站:GSK046
产品活性:GSK046 (iBET-BD2) 是一种有效,选择性和具有口服活性的 BET 蛋白 BD2 溴结构域的抑制剂,IC50 值为 264 nM (BRD2 BD2),98 nM (BRD3 BD2),49 nM (BRD4 BD2) 和 214 nM (BRDT BD2)。GSK046 具有免疫调节活性。
研究领域:Epigenetics
In Vitro: GSK046 (1000 nM; refresh every three days) reduces the recruitment of BET proteins to interferon (IFN) target genes following IFN-γ stimulation. GSK046 appears to more prominently affect the recruitment of BRD2 and BRD3 compared to BRD4.
GSK046 (0.1-10 μM) displays a more selective phenotypic fingerprint, particularly inhibiting the production of key pro-inflammatory mediators including Th17 cytokines in the B and T cell co-culture system.
GSK046 (0.01-10 μM; 72 hours) does not affect the proliferative activity of human primary CD4+ T cells but still inhibits the production of effector cytokines including IFNγ, IL-17A and IL-22.
GSK046 (0.005-10 μM; 48 hours) impairs macrophage activation following PMA stimulation, without impacting cellular viability.
In Vivo: GSK046 (40 mg/kg/QD; s.c. for 14 days) has immunomodulatory activity.
GSK046 exhibits Cmax (C57BL6 1589, C57B16 2993 ng/mL) and terminal elimination half-lives (C57BL6 1.8, C57B16 1.9 h) following oral administration (C57BL6 10, C57B16 40 mg/kg).
GSK046 exhibits Cmax (mouse 1589, rat 202 ng/mL) and terminal elimination half-lives (mouse 1.8, rat 1.4 h) following oral administration (mouse 10, rat 10 mg/kg).
相关产品:Bioactive Compound Library Plus | Epigenetics Compound Library | Immunology/Inflammation Compound Library | Histone Modification Research Compound Library | Reprogramming Compound Library | Orally Active Compound Library | Anti-Blood Cancer Compound Library | A-485 | Curcumin | Birabresib | C646 | JQ-1 (carboxylic acid) | Anacardic Acid | I-BET151 | SGC-CBP30 | MG 149 | KG-501 | A-366 | CPI-203 | NSC 228155 | PFI-1 | GSK2801 | ACBI1 | IACS-9571 hydrochloride | MI-3 | (+)-JQ1 PA | PF-CBP1 hydrochloride | SGC-iMLLT | Bromosporine | EML 425 | HJB97 | MS436 | CeMMEC1 | GSK1379725A | GSK6853 | MS31 trihydrochloride | MS645
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:12:11
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品